|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss before equity method investment income (loss) | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Gain on deconsolidation of the JV Company | |||||
| Loss on changes of equity interest in the JV Company, net | |||||
| Deferred income tax on deconsolidation and changes of equity interest in the JV Company | |||||
| Depreciation and amortization | |||||
| Equity method investment loss from equity investee | |||||
| Equity method investment income (loss) | |||||
| Gain on recovery of privately-held investment | |||||
| Share-based compensation expense | |||||
| Deferred income taxes, net | |||||
| Loss on disposal of property and equipment | |||||
| Impairment of property and equipment | |||||
| Impairment of privately-held investment | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current and long-term assets | |||||
| Payable related to equity investee, net | |||||
| Accounts payable | |||||
| Income taxes payable | |||||
| Income taxes payable on deconsolidation and changes of equity interest in the JV Company | |||||
| Deferred revenue | |||||
| Accrued and other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Deconsolidation of cash and cash equivalents of the JV Company | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of privately-held investment | |||||
| Government grants related to equipment | |||||
| Loan receivable from suppliers | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Withholding tax on restricted stock units | |||||
| Proceeds from exercise of stock options and ESPP | |||||
| Payments for repurchase of common shares | |||||
| Proceeds from borrowings | |||||
| Repayments of borrowings | |||||
| Principal payments on finance leases | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing information: | |||||
| Property and equipment purchased but not yet paid | |||||
| Reissuance of treasury stock | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...